Deborah Fine

A dynamic C-suite commercialization executive and proven CEO, leading 6 diverse B2B and B2C businesses to record growth and profit in both public and private companies, ranging from start up to $1 billion in revenue. Industry experience includes healthcare, consumer products, retail via direct to consumer and wholesale channels, and media. An innovative leader consistently able to drive growth in start up environments as well as large, matrixed organizations. Strong track record of attracting and retaining top talent to develop results-driven executive teams.

Exceptional communicator who formulates highly resonant messaging resulting in scaled adoption of new products, services, technologies, and business models. Deep expertise and a novel approach to building impactful strategic alliances of scale across key stakeholder groups and industry sectors, most recently with healthcare Key Opinion Leaders from hospital systems, academic medical institutions, physician chairs, government agencies, employer networks, patient advocacy groups, professional organizations, government and commercial payers, financial institutions, and biotech service providers.

Current member of 8 boards and councils, primarily focused on digital health, biotechnology, and ESG, including Laguna Health, Springboard Enterprise Life Sciences Council, The United Nations Development Programme, MIT ReACT, and Harvard Women’s Leadership Board.